Eisai
4523.T
#2149
Rank
S$11.82 B
Marketcap
S$41.96
Share price
1.81%
Change (1 day)
9.38%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.10. an increase over its 2024 EPS that were of S$1.23.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.3811.85%
2024S$1.23-32.63%
2023S$1.835.52%
2022S$1.74-74.01%
2021S$6.68-66.58%
2020S$19.9998.24%
2019S$10.0817.01%
2018S$8.6237.78%
2017S$6.25-27.62%
2016S$8.6435.33%
2015S$6.39-2.82%
2014S$6.57-27.66%
2013S$9.08-27.49%
2012S$12.53-12.67%
2011S$14.3588.08%
2010S$7.63-11.06%
2009S$8.58-390.15%
2008S-$2.96-127.78%
2007S$10.6411.78%
2006S$9.524.38%
2005S$9.127.4%
2004S$8.4943.03%
2003S$5.9425.09%
2002S$4.7552.67%
2001S$3.1169.76%
2000S$1.83